These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 9444989)

  • 1. Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse.
    Moffat JF; Zerboni L; Kinchington PR; Grose C; Kaneshima H; Arvin AM
    J Virol; 1998 Feb; 72(2):965-74. PubMed ID: 9444989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model.
    Zerboni L; Hinchliffe S; Sommer MH; Ito H; Besser J; Stamatis S; Cheng J; Distefano D; Kraiouchkine N; Shaw A; Arvin AM
    Virology; 2005 Feb; 332(1):337-46. PubMed ID: 15661165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice.
    Moffat JF; Stein MD; Kaneshima H; Arvin AM
    J Virol; 1995 Sep; 69(9):5236-42. PubMed ID: 7636965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varicella-zoster virus open reading frame 10 is a virulence determinant in skin cells but not in T cells in vivo.
    Che X; Zerboni L; Sommer MH; Arvin AM
    J Virol; 2006 Apr; 80(7):3238-48. PubMed ID: 16537591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular studies of the Oka varicella vaccine.
    Quinlivan M; Breuer J; Schmid DS
    Expert Rev Vaccines; 2011 Sep; 10(9):1321-36. PubMed ID: 21919621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an important immunological difference between virulent varicella-zoster virus and its avirulent vaccine: viral disruption of dendritic cell instruction.
    Gutzeit C; Raftery MJ; Peiser M; Tischer KB; Ulrich M; Eberhardt M; Stockfleth E; Giese T; Sauerbrei A; Morita CT; Schönrich G
    J Immunol; 2010 Jul; 185(1):488-97. PubMed ID: 20525895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immediate-early 63 protein of Varicella-Zoster virus: analysis of functional domains required for replication in vitro and for T-cell and skin tropism in the SCIDhu model in vivo.
    Baiker A; Bagowski C; Ito H; Sommer M; Zerboni L; Fabel K; Hay J; Ruyechan W; Arvin AM
    J Virol; 2004 Feb; 78(3):1181-94. PubMed ID: 14722273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varicella-zoster virus glycoprotein E is a critical determinant of virulence in the SCID mouse-human model of neuropathogenesis.
    Zerboni L; Berarducci B; Rajamani J; Jones CD; Zehnder JL; Arvin A
    J Virol; 2011 Jan; 85(1):98-111. PubMed ID: 20962081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse.
    Moffat JF; Zerboni L; Sommer MH; Heineman TC; Cohen JI; Kaneshima H; Arvin AM
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11969-74. PubMed ID: 9751774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of open reading frames 62 and 71, encoding the varicella-zoster virus immediate-early transactivating protein, IE62, and effects on replication in vitro and in skin xenografts in the SCID-hu mouse in vivo.
    Sato B; Ito H; Hinchliffe S; Sommer MH; Zerboni L; Arvin AM
    J Virol; 2003 May; 77(10):5607-20. PubMed ID: 12719553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varicella-zoster virus T cell tropism and the pathogenesis of skin infection.
    Arvin AM; Moffat JF; Sommer M; Oliver S; Che X; Vleck S; Zerboni L; Ku CC
    Curr Top Microbiol Immunol; 2010; 342():189-209. PubMed ID: 20397071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Human Skin Tissue Model To Study Varicella-Zoster Virus and Human Cytomegalovirus.
    Lloyd MG; Smith NA; Tighe M; Travis KL; Liu D; Upadhyaya PK; Kinchington PR; Chan GC; Moffat JF
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32878893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of varicella-zoster virus recombinants from parent Oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID-hu mouse model.
    Niizuma T; Zerboni L; Sommer MH; Ito H; Hinchliffe S; Arvin AM
    J Virol; 2003 May; 77(10):6062-5. PubMed ID: 12719598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell tropism and the role of ORF66 protein in pathogenesis of varicella-zoster virus infection.
    Schaap A; Fortin JF; Sommer M; Zerboni L; Stamatis S; Ku CC; Nolan GP; Arvin AM
    J Virol; 2005 Oct; 79(20):12921-33. PubMed ID: 16188994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of varicella-zoster virus neurotropism and neurovirulence using SCID mouse-human DRG xenografts.
    Zerboni L; Arvin A
    J Neurovirol; 2011 Dec; 17(6):570-7. PubMed ID: 22161683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functions of the C-terminal domain of varicella-zoster virus glycoprotein E in viral replication in vitro and skin and T-cell tropism in vivo.
    Moffat J; Mo C; Cheng JJ; Sommer M; Zerboni L; Stamatis S; Arvin AM
    J Virol; 2004 Nov; 78(22):12406-15. PubMed ID: 15507627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with recombinant varicella-zoster virus expressing herpes simplex virus type 2 glycoprotein D reduces the severity of genital herpes in guinea pigs.
    Heineman TC; Connelly BL; Bourne N; Stanberry LR; Cohen J
    J Virol; 1995 Dec; 69(12):8109-13. PubMed ID: 7494331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells.
    Moffat J; Ito H; Sommer M; Taylor S; Arvin AM
    J Virol; 2002 Aug; 76(16):8468-71. PubMed ID: 12134050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenesis of varicella-zoster virus glycoprotein B: putative fusion loop residues are essential for viral replication, and the furin cleavage motif contributes to pathogenesis in skin tissue in vivo.
    Oliver SL; Sommer M; Zerboni L; Rajamani J; Grose C; Arvin AM
    J Virol; 2009 Aug; 83(15):7495-506. PubMed ID: 19474103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus.
    Sommer MH; Zagha E; Serrano OK; Ku CC; Zerboni L; Baiker A; Santos R; Spengler M; Lynch J; Grose C; Ruyechan W; Hay J; Arvin AM
    J Virol; 2001 Sep; 75(17):8224-39. PubMed ID: 11483768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.